-
2
-
-
0033023072
-
New treatment strategies for malignant gliomas.
-
3
-
NG Avgeropoulos TT Batchelor 1999 New treatment strategies for malignant gliomas. Oncologist 4 3 209 224
-
(1999)
Oncologist
, vol.4
, pp. 209-224
-
-
Avgeropoulos, N.G.1
Batchelor, T.T.2
-
3
-
-
0035031195
-
Introduction: The history of arsenic trioxide in cancer therapy.
-
S2
-
KH Antman 2001 Introduction: the history of arsenic trioxide in cancer therapy. Oncologist 6 S2 1 2
-
(2001)
Oncologist
, vol.6
, pp. 1-2
-
-
Antman, K.H.1
-
4
-
-
0348014917
-
Arsenic trioxide enhances radiation response of 9L glioma in the rat brain.
-
6
-
JH Kim YS Lew A Kolozsvary 2003 Arsenic trioxide enhances radiation response of 9L glioma in the rat brain. Radiat Res 160 6 662 666
-
(2003)
Radiat Res
, vol.160
, pp. 662-666
-
-
Kim, J.H.1
Lew, Y.S.2
Kolozsvary, A.3
-
5
-
-
4444346338
-
Increased cure rate of glioma using concurrent therapy with radiotherapy and arsenic trioxide.
-
1
-
S Ning SJ Knox 2004 Increased cure rate of glioma using concurrent therapy with radiotherapy and arsenic trioxide. Int J Radiation Oncology Biol Phys 60 1 197 203
-
(2004)
Int J Radiation Oncology Biol Phys
, vol.60
, pp. 197-203
-
-
Ning, S.1
Knox, S.J.2
-
6
-
-
0032933610
-
Malignant cells can be sensitised to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
-
1
-
J Dai SR Weinberg S Waxman Y Jing 1999 Malignant cells can be sensitised to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93 1 268 277
-
(1999)
Blood
, vol.93
, pp. 268-277
-
-
Dai, J.1
Weinberg, S.R.2
Waxman, S.3
Jing, Y.4
-
7
-
-
0031657760
-
Involvement of reactive oxygen species and caspase 3 activation in arsenic-induced apoptosis.
-
2
-
YC Chen SY Lin-shiau JK Lin 1998 Involvement of reactive oxygen species and caspase 3 activation in arsenic-induced apoptosis. J Cell Physiol 177 2 324 333
-
(1998)
J Cell Physiol
, vol.177
, pp. 324-333
-
-
Chen, Y.C.1
Lin-Shiau, S.Y.2
Lin, J.K.3
-
8
-
-
0034212785
-
Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
-
11
-
WH Park JG Seol ES Kim 2000 Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60 11 3065 3071
-
(2000)
Cancer Res
, vol.60
, pp. 3065-3071
-
-
Park, W.H.1
Seol, J.G.2
Kim, E.S.3
-
9
-
-
0033526358
-
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
-
9
-
XH Zhu YL Shen YK Jing 1999 Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst 91 9 772 778
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 772-778
-
-
Zhu, X.H.1
Shen, Y.L.2
Jing, Y.K.3
-
10
-
-
0038743077
-
Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.
-
9
-
T Kanzawa Y Kondo H Ito 2003 Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 63 9 2103 2108
-
(2003)
Cancer Res
, vol.63
, pp. 2103-2108
-
-
Kanzawa, T.1
Kondo, Y.2
Ito, H.3
-
11
-
-
13944256602
-
Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.
-
6
-
T Kanzawa L Zhang L Xiao 2005 Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24 6 980 991
-
(2005)
Oncogene
, vol.24
, pp. 980-991
-
-
Kanzawa, T.1
Zhang, L.2
Xiao, L.3
-
12
-
-
0036653125
-
Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioma cell lines differing in p53 status.
-
1
-
S Zhao T Tsuchida K Kawakami 2002 Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioma cell lines differing in p53 status. Int J Oncol 21 1 49 55
-
(2002)
Int J Oncol
, vol.21
, pp. 49-55
-
-
Zhao, S.1
Tsuchida, T.2
Kawakami, K.3
-
13
-
-
0026777319
-
Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioma cell.
-
8
-
SJ Ullrich WE Mercer E Appella 1992 Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioma cell. Oncogene 7 8 1635 1643
-
(1992)
Oncogene
, vol.7
, pp. 1635-1643
-
-
Ullrich, S.J.1
Mercer, W.E.2
Appella, E.3
-
16
-
-
9244224723
-
Intrinsic tumor suppression.
-
7015
-
SW Lowe E Cepero G Evan 2004 Intrinsic tumor suppression. Nature 432 7015 307 315
-
(2004)
Nature
, vol.432
, pp. 307-315
-
-
Lowe, S.W.1
Cepero, E.2
Evan, G.3
-
17
-
-
0030768779
-
Regulation of transcription by proteins that control cell cycle.
-
6647
-
BD Dynlacht 1997 Regulation of transcription by proteins that control cell cycle. Nature 389 6647 149 152
-
(1997)
Nature
, vol.389
, pp. 149-152
-
-
Dynlacht, B.D.1
-
18
-
-
0035810054
-
Regulation of the G2/M transition by p53.
-
15
-
WR Taylor GR Stark 2001 Regulation of the G2/M transition by p53. Oncogene 20 15 1803 1815
-
(2001)
Oncogene
, vol.20
, pp. 1803-1815
-
-
Taylor, W.R.1
Stark, G.R.2
-
19
-
-
0033066323
-
Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase3 in vitro.
-
1-2
-
Y Akao Y Nakagawa K Akiyama 1999 Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase3 in vitro. FEBS Lett 455 1-2 59 62
-
(1999)
FEBS Lett
, vol.455
, pp. 59-62
-
-
Akao, Y.1
Nakagawa, Y.2
Akiyama, K.3
-
20
-
-
10844264632
-
Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: Reactive oxygen species-mediated poly (ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria.
-
24
-
YH Kang MJ Yi MJ Kim 2004 Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly (ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res 64 24 8960 8967
-
(2004)
Cancer Res
, vol.64
, pp. 8960-8967
-
-
Kang, Y.H.1
Yi, M.J.2
Kim, M.J.3
-
21
-
-
0034490080
-
Arsenic Trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian cell lines.
-
12
-
R Uslu UA Sanli C Sezgin 2000 Arsenic Trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian cell lines. Clin Cancer Res 61 12 4957 4964
-
(2000)
Clin Cancer Res
, vol.61
, pp. 4957-4964
-
-
Uslu, R.1
Sanli, U.A.2
Sezgin, C.3
-
22
-
-
0035879016
-
Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
-
14
-
H Maeda S Hori H Nishitoh 2001 Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 61 14 5432 5440
-
(2001)
Cancer Res
, vol.61
, pp. 5432-5440
-
-
Maeda, H.1
Hori, S.2
Nishitoh, H.3
-
23
-
-
0037192453
-
Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines.
-
19
-
Y Nakagawa Y Akao H Morikawa 2002 Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines. Life Sci 70 19 2253 2262
-
(2002)
Life Sci
, vol.70
, pp. 2253-2262
-
-
Nakagawa, Y.1
Akao, Y.2
Morikawa, H.3
-
24
-
-
0036295558
-
Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
-
4
-
M Kito Y Akao N Ohishi 2002 Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 291 4 861 867
-
(2002)
Biochem Biophys Res Commun
, vol.291
, pp. 861-867
-
-
Kito, M.1
Akao, Y.2
Ohishi, N.3
-
25
-
-
0032773828
-
Induction of apoptosis and inhibition of human gastric cancer MCG-803 cell growth by arsenic trioxide.
-
8
-
TC Zhang EH Cao JF Li 1999 Induction of apoptosis and inhibition of human gastric cancer MCG-803 cell growth by arsenic trioxide. Eur J Cancer 35 8 1258 1263
-
(1999)
Eur J Cancer
, vol.35
, pp. 1258-1263
-
-
Zhang, T.C.1
Cao, E.H.2
Li, J.F.3
-
26
-
-
0036250205
-
Arsenic trioxide as a novel anticancer agent against human transitional carcinoma characterizing its apoptotic pathway.
-
3
-
YS Pu TC Hour J Chen 2002 Arsenic trioxide as a novel anticancer agent against human transitional carcinoma characterizing its apoptotic pathway. Anticancer Drugs 13 3 293 300
-
(2002)
Anticancer Drugs
, vol.13
, pp. 293-300
-
-
Pu, Y.S.1
Hour, T.C.2
Chen, J.3
-
27
-
-
0033787018
-
Effect of arsenic trioxide on human hepatoma cell line BEL-7402 cultured in vitro.
-
5
-
HY Yu YL Yang YY Gao 2000 Effect of arsenic trioxide on human hepatoma cell line BEL-7402 cultured in vitro. World J Gastroenterol 6 5 681 687
-
(2000)
World J Gastroenterol
, vol.6
, pp. 681-687
-
-
Yu, H.Y.1
Yang, Y.L.2
Gao, Y.Y.3
-
28
-
-
0035874054
-
Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide.
-
4
-
K Iwama S Nakajo T Aiuchi K Nakaya 2001 Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int J Cancer 92 4 518 526
-
(2001)
Int J Cancer
, vol.92
, pp. 518-526
-
-
Iwama, K.1
Nakajo, S.2
Aiuchi, T.3
Nakaya, K.4
|